ANAPTYSBIO, INC Research And Development Expense

Quick Answer

ANAPTYSBIO, INC reported Research And Development Expense of $88.80 million for the year ending 2022.

  • ANAPTYSBIO, INC showed a decrease of -9.8% in Research And Development Expense from 2021 to 2022.
  • This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 1, 2023.
  • XBRL data for this metric is available from 2015 to 2022 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2015 to 2022), ANAPTYSBIO, INC's Research And Development Expense has grown by 413.2%.
  • Historical annual values: Fiscal year 2022: $88.80 million | Fiscal year 2021: $98.50 million | Fiscal year 2020: $80.03 million | Fiscal year 2019: $99.34 million | Fiscal year 2018: $56.20 million | Fiscal year 2017: $29.44 million | Fiscal year 2016: $15.42 million | Fiscal year 2015: $17.30 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: